SARS-CoV-2 IgG-IgM positive | SARS-CoV-2 IgG-IgM negative | |
Samples analyzed | 83 (5%) | 1503 (95%) |
Median age (IQR*) | 43 (32 - 55) | 46 (35.5 - 56) |
Sex | ||
Male | 36 (43%) | 722 (48%) |
Female | 47 (57%) | 781 (52%) |
Age, years |
|
|
4 - 20 | 5 (6%) | NA |
21 - 64 | 72 (87%) | NA |
≥65 | 6 (7%) | NA |
Presenting symptoms | 38 (45%) | 95 (6.3%) |
Fever | 21 (25%) | 38 (2.5%) |
Cough | 4 (4.8%) | 16 (1%) |
Bronchitis | 1 (1.2%) | ND |
Fever, diarrhea | 1 (1.2%) | 23 (1.5%) |
Fever, Cough, Olfactory and Gustatory dysfunctions | 2 (2.4%) | ND |
Olfactory and Gustatory dysfunctions | 3 (3.6%) | 7 (0.4%) |
Olfactory and Gustatory dysfunctions, Fever | 2 (2.4%) | 5 (0.5%) |
Olfactory dysfunction | 4 (4.8%) | 2 (0.1%) |
Gastrointestinal dysfunction | ND | 4 (3%) |
Laboratory results |
|
|
IgG-positive | 37 (45%) | ND |
IgM-positive | 6 (7%) | ND |
IgG & IgM-positive | 40 (48%) | ND |